NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

California-based Aerie Pharmaceuticals, a clinical-stage company developing new treatments for glaucoma and other eye diseases, is expanding its R&D operations in Durham as some of its drug candidates move closer to commercialization.

Chapel Hill-based Cempra, a publicly held pharmaceutical company developing treatments for infectious diseases, plans to merge with privately held Melinta Therapeutics, an antibiotics developer based in New Haven, Conn.

Pfizer, the global pharmaceutical giant, will expand its vaccine-manufacturing plant in Sanford with a $100 million investment in gene therapy that will add 40 jobs to its workforce.

Citing the Research Triangle region’s prevalence of top talent and nationally ranked research universities, New Jersey-based Lifestar Pharma has purchased a Durham building for a new R&D and manufacturing operation.

Scott Levitan starts a new job today, as president and CEO of The Research Foundation of NC.

BioFluidica, a Chapel Hill company developing a product using liquid biopsies for cancer detection, has raised $4.1 million in a private equity offering. 

TransEnterix, a Morrisville medical device company that uses robotics to improve minimally invasive surgery, says European surgeons have performed the first 3-millimeter micro laparoscopic robotic surgeries in the world using the company's Senhance Surgical Robot.

Burlington-based LabCorp, the global life sciences company built on laboratory diagnostic testing, anounced plans to acquire Chiltern International, a privately held contract research organization (CRO) that has its North American headquarters in Wilmington, for about $1.2 billion.

Earlier this summer the North Carolina Biotechnology Center campus was buzzing – with bees.

NCBiotech supports life science research across the state. But it normally doesn’t actually participate in research studies from its Research Triangle Park headquarters or from its five regional offices across the state.

A public/private partnership is providing biology and chemistry majors at the University of North Carolina Wilmington with unique insight into the pharmaceutical services industry.

Premex Innovation Labs, a Colombia, South America-based animal and human nutrition company, is holding an open house at its new U.S. headquarters in Durham.

Participants and vendors have only a few weeks left to get tiny pricing for Nano Manufacturing 2017, a conference devoted to the production of extremely small things, scheduled for Wednesday, Sept. 27, in Greensboro.

The price is right – free -- and the content is rich. It’s the newly published 2017-18 print edition of the NCBiotech Company Directory.

Alcami, a leading product development and manufacturing services provider for the pharmaceutical and biotechnology sectors, plans to finish relocating its international headquarters from Wilmington to Durham in 2018.

Durham-based BioLabs North Carolina is about to become an expanded part of a national network of co-working facilities helping science-based startups go further faster with limited capital investment.